EPIC Program Annual Data Tables 2004-2005: Table VII

Table VII
Ten Most Frequently Purchased Types of Drugs
by Therapeutic Classification^*

Therapeutic Class	Number of Claims	Percent of Claims	EPIC Payments	Number of Participants
Total	4,825,746	43.41%	$307,230,274
BETA-ADRENERGIC BLOCKING AGENT	819,451	7.36%	$23,031,335	151,542
HMG-COA REDUCTASE INHIBITORS	659,984	5.94%	$91,314,866	150,138
DIURETICS	632,033	5.69%	$4,621,125	136,947
ANGIOTENSIN-CONVERTING ENZYME	576,538	5.19%	$20,037,303	110,002
PROTON-PUMP INHIBITORS	393,461	3.54%	$70,823,956	93,950
DIHYDROPYRIDINES	378,745	3.41%	$27,034,287	77,890
ANTIDEPRESSANTS	372,810	3.35%	$26,529,684	70,345
OPIATE AGONISTS	342,342	3.08%	$14,192,485	89,539
ANGIOTENSIN II RECEPTOR ANTAGO	337,528	3.04%	$25,411,660	71,419
THYROID AGENTS	312,854	2.81%	$4,233,573	59,643

^* Table VII provides the percent of adjudicated claims for the program year (October 1, 2004 through September 30, 2005) as they fall into particular categories of Therapeutic Class.

^** American Hospital Formulary Service® (AHFS) Pharmacologic-Therapeutic Classification.

^*** This report contains the top ten drug classes; additional drug classes comprise the remainder of claims up to 100.00%.